VANCOUVER, Washington, May 27, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140...
VANCOUVER, Washington, April 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5...
WESTLAKE VILLAGE, Calif. and BELO HORIZONTE, Brazil, June 03, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that Afrezza® (insulin human...
VALENCIA, Calif. and BELO HORIZONTE, Brazil, May 31, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that they have entered...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17 | 1.93621867882 | 8.78 | 9.08 | 8.48 | 37080 | 8.82510248 | CS |
4 | -0.95 | -9.59595959596 | 9.9 | 10 | 8.48 | 48105 | 9.04230849 | CS |
12 | -0.84 | -8.58018386108 | 9.79 | 11.4 | 7.79 | 84633 | 9.27678161 | CS |
26 | -9.55 | -51.6216216216 | 18.5 | 18.89 | 7.79 | 121816 | 13.16441795 | CS |
52 | 3.96 | 79.3587174349 | 4.99 | 21.2 | 4.67 | 97569 | 12.85300807 | CS |
156 | -4.77 | -34.7667638484 | 13.72 | 21.2 | 3.1 | 43152 | 11.51914928 | CS |
260 | 0.72 | 8.74848116646 | 8.23 | 29 | 3.1 | 38093 | 12.96568826 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.